Home›Search›Geneesmiddelenbulletin

Geneesmiddelenbulletin

Stichting Geneesmiddelenbulletin · Netherlands

ISSN0304-4629

SJR Q4✓ Scopus / SJR

/ 100

Established

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q446

Total46

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Bottom 25%

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Scorei

0.101

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

Total Worksi

318

Total Citationsi

2yr Mean Citednessi

0.03

Open Impact Factor alternative

Aims & Scope

Geneesmiddelenbulletin (Ge-Bu) is an independent journal that provides objective information about medicines. It aims to inform healthcare professionals about new drugs, treatment guidelines, and drug safety. The journal publishes reviews, updates, and articles on various therapeutic areas, with a focus on evidence-based medicine and drug efficacy and safety.

General Information

Country / RegionNetherlands

Primary LanguageDutch

1st Year Published—

Annual Volume~ 49 articles / year

StatusActive

Total Publications318

Visit Journal Website

Submission Info

Publishing ModelSubscription

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Stichting Geneesmiddelenbulletin

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

0304-4629

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

Dutch

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

PharmacologyQ4

Pharmacology (medical)Q4

Subject Classification

Scopus Categories

PharmacologyPharmacology (medical)

Research Topics (OpenAlex)

Diet and metabolism studiesDiabetes Treatment and ManagementPharmaceutical studies and practicesCOVID-19 Clinical Research StudiesDiabetes Management and Research

Frequently asked questions about Geneesmiddelenbulletin

Is Geneesmiddelenbulletin a predatory journal?

PubScope has no integrity flags on record for Geneesmiddelenbulletin: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 46/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Geneesmiddelenbulletin?

Geneesmiddelenbulletin is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.101.

Is Geneesmiddelenbulletin indexed in Scopus and Web of Science?

Geneesmiddelenbulletin is indexed in Scopus.